Biotech Values

[JohnWayne]

I may have read too much into mgmt's vague language... in recent Q2 call the CSO said he'd walk through the "analytical hierarchy" for 026, but never actually stated that they'd analyze from high to low cutoffs. Somewhat baffling to me that they didn't look higher than 5%.